Skip to content
SentinelMarket desk
Switch to dark mode

티앤엘

340570KOSDAQView the 제약 sectorTheme Bio & healthcare

25,600KRWMarket close of 10/21 (Wed)

Down -1.16%-300KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)24,600KRWDown -3.91%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
26,100
High
26,400
Low
25,400
Day range
Day range low 25,400 high 26,400, open 26,100, close 25,600, previous close 25,900
Volume
2×10K shares
441.69 million KRW 0.25× the 20-session average

Market close of 10/21 (Wed)

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range-1.16%-1.16%, 0.6× the usual (20-session average ±1.96%)
    That day -1.16% · usual ±1.96% · large-move threshold ±3.9%

The other 3 are within the usual range

  • Trading value0.2×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue45.1B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -12.2%
    vs. prior quarter
    +34.9%
  • Operating income18.3B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -9.7%
    vs. prior quarter
    +354.3%
  • Operating margin40.5%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +1.1 pp
    vs. prior quarter
    +28.5 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15
2021Q1 3.6B KRW2026Q1 18.3B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.